Safety of proton pump inhibitors based on a large, multi-year, randomized trial of patients receiving rivaroxaban or aspirin

P Moayyedi, JW Eikelboom, J Bosch, SJ Connolly… - Gastroenterology, 2019 - Elsevier
Background & Aims Proton pump inhibitors (PPIs) are effective at treating acid-related
disorders. These drugs are well tolerated in the short term, but long-term treatment was …
被引用次数：483 相关文章

[引用][C] Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

P Moayyedi, JW Eikelboom, J Bosch, SJ Connolly… - Gastroenterology, 2019 - cir.nii.ac.jp
Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients
Receiving Rivaroxaban or Aspirin | CiNii Research CiNii 国立情報学研究所 学術情報ナビゲータ …
[HTML] gastrojournal.org

[HTML][HTML] Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

P Moayyedi, JW Eikelboom, J Bosch… - …, 2019 - gastrojournal.org
Background & Aims Proton pump inhibitors (PPIs) are effective at treating acid-related
disorders. These drugs are well tolerated in the short term, but long-term treatment was …

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin.

P Moayyedi, JW Eikelboom, J Bosch, SJ Connolly… - …, 2019 - europepmc.org
Methods We performed a 3× 2 partial factorial double-blind trial of 17,598 participants with
stable cardiovascular disease and peripheral artery disease randomly assigned to groups …
[PDF] chapman.edu

[PDF][PDF] Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

P Moayyedi, JW Eikelboom… - …, 2019 - digitalcommons.chapman.edu
Many studies have linked proton pump inhibitor (PPI) use to several adverse effects
including Clostridium difficile-associated diarrhea, community-acquired pneumonia, bone …
[PDF] sakura.ne.jp

[PDF][PDF] Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

P Moayyedi, JW Eikelboom, J Bosch, SJ Connolly… - saigaiin.sakura.ne.jp
Methods We performed a 3× 2 partial factorial double-blind trial of 17,598 participants with
stable cardiovascular disease and peripheral artery disease randomly assigned to groups …

Safety of Proton Pump Inhibitors Based on a Large, Multi-year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

P Moayyedi, JW Eikelboom, J Bosch, SJ Connolly… - …, 2019 - ruj.uj.edu.pl
Safety of Proton Pump Inhibitors Based on a Large, Multi-year, Randomized Trial of Patients
Receiving Rivaroxaban or Aspirin Przejdź do treści Pomoc A A A Zmień kontrast Zaloguj …

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

P Moayyedi, JW Eikelboom, J Bosch, SJ Connolly… - 2019 - pubmed.ncbi.nlm.nih.gov
Background & aims Proton pump inhibitors (PPIs) are effective at treating acid-related
disorders. These drugs are well tolerated in the short term, but long-term treatment was …

Safety of Proton Pump Inhibitors Based on a Large, Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

P Moayyedi, JW Eikelboom, J Bosch, SJ Connolly… - Gastroenterology, 2019 - vbn.aau.dk
BACKGROUND & AIMS: Proton pump inhibitors (PPIs) are effective at treating acid-related
disorders. These drugs are well tolerated in the short term, but long-term treatment was …

Safety of Proton Pump Inhibitors Based on a Large, Multi-year, Randomized Trial of Patients Receiving Rivaroxaban or Aspirin

COMPASS Investigators - Gastroenterology, 2019 - research.regionh.dk
BACKGROUND & AIMS: Proton pump inhibitors (PPIs) are effective at treating acid-related
disorders. These drugs are well tolerated in the short term, but long-term treatment was …